SANUWAVE Health Hits 52-Week Low at $18.61 Amid Market Volatility

SANUWAVE Health, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 18.61 on March 26, 2026. This significant decline highlights the stock's recent performance, contrasting sharply with its 52-week high of USD 46.59. Over the past year, SANUWAVE Health has experienced a performance shift, with its stock price reflecting a notable deviation from broader market trends, as evidenced by its performance compared to the S&P 500, which stands at 13.39%. The company's market capitalization is currently valued at approximately USD 190 million, indicating its microcap status within the industry. Financial metrics reveal a price-to-earnings (P/E) ratio of 46.00, while the company does not offer a dividend yield. Additionally, SANUWAVE Health's debt-to-equity ratio is reported at -4.76, and its return on equity is notably low at -999,999.00%. The price-to-book ratio stands at -64.94, further illustrating the company's current financial landscape.